+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Corneal Implants Market by Transplant Type, Indication (Ocular Cicatricial Pemphigoid, Implant Type, End Use, and by Region - Global Forecast to 2022-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717260
The artificial corneal implants market size is estimated to be USD 75.84 million in 2022 and is expected to witness a CAGR of 7.47% during the forecast period 2023-2033. Surge in the number of chronic diseases such as hypertension and diabetes and escalating for corneal transplants are some of the factors contributing to the market growth. Furthermore, increase in the number of eye problems and large patient base and scarcity of potential donors are other factors supporting the market growth. However, high cost of artificial corneal implants and lack of skilled professionals is expected to hinder the growth.

Increase in the number of eye problems is expected to propel the market growth during the projected period. A significant market driver is the rise in eye-related conditions such as ocular cicatricial pemphigoid, keratoconus, corneal stromal dystrophies, ocular cicatricial pemphigoid, and infectious keratitis. According to studies, 50 to 200 people out of every 100,000 people have keratoconus. The frequency in the US is at 54.5 per 100,000 people. Globally, 10 million individuals are affected with corneal blindness, which is the third most common cause of blindness after glaucoma and cataracts. The Eye Bank Association of America reported in a research article from 2021 that 200,000 corneal implant surgeries are expected to be carried out annually.

Large patient base and scarcity of potential donors is predicted to fuel the market growth during the projected period. Around 12.7 million people worldwide are reportedly waiting for corneal transplants, meaning that only 1 in every 70 people who require a transplant is actually given one, according to a Harvard Medical School article. To address the lack of donor tissue and the issues with corneal donor transplantation, significant efforts have been undertaken to develop substitutes for human donor corneas. This has increased the use of artificial corneal implants.

By Transplant Type

The market is categorized into soft keratoprosthesis and hard keratoprosthesis. In the global market, the hard keratoprosthesis segment accounted for the largest revenue share in 2022 owing to the products' widespread acceptance, particularly Boston Kpro. It is the most popular artificial cornea, and recent times have witnessed an exponential rise in its use due to better outcomes from ongoing design improvements and superior postoperative care. The Harvard Medical School's department of ophthalmology stated in a study paper from 2022 that 598 surgeons have used Boston Kpro in more than 11,000 implantations that have taken place to far in 66 countries and over 11,000 patients. However, the soft keratoprosthesis segment is anticipated to increase at the fastest rate due to the introduction of new products. For instance, EyeYon Medical Ltd. reported in February 2020 that the FDA had given its EndoArt, an artificial endothelial layer implant, Breakthrough Status Designation. In June 2021, the business gained CE Mark approval for its EndoArt Implant to treat chronic corneal edoema.

By Indication

The market is divided into ocular cicatricial pemphigoid (OCP), Stevens-Johnson syndrome (SJS), keratoconus, ocular burns, corneal stromal dystrophies, and others. In 2022, the keratoconus segment accounted for the highest revenue share due to disease's rising prevalence globally. One in five people with keratoconus advances to the level that a corneal implant is required to restore normal vision, according to the Cancer Research Foundation of America. The segment growth is also anticipated to be propelled by patients with keratoconus increasingly using artificial corneal implants. The Ocular Cicatricial Pemphigoid (OCP) segment is anticipated to experience the maximum expansion over the forecast period. The main reason fuelling the segment's rise is the increase in public awareness of eye problems. Ocular burns are also anticipated to have considerable expansion during the predicted period as a result of the rise in burn cases in various settings.

By Implant Type

The market is segregated into biosynthetic, and synthetic. In the global market, the synthetic segment accounted for the largest revenue share in 2022 owing to the fact that more synthetic artificial corneal implants available on the market than biosynthetic products, which increases adoption rates. Additionally, companies are concentrating on creating synthetic artificial corneal implants. For instance, CorNeat Kpro is a synthetic cornea that offers a long-lasting medical remedy for corneal blindness, disease, and injury. It is currently undergoing clinical trials and is scheduled to be released in 2023. The segment is anticipated to rise exponentially as manufacturers concentrate on creating synthetic corneal implants and due to a robust product pipeline. Moreover, the biosynthetic segment is anticipated to develop slowly throughout the forecast period as a result of this trend toward synthetic corneal implants.

By End Use

The market is segmented into ambulatory surgical centers, hospitals, and ophthalmic centers. In 2022, the hospitals segment accounted for the largest revenue share owing to availability of highly experienced surgeons and the increasing number of patients. On the other hand, the ambulatory surgical centre (ASC) segment is predicted to develop at the fastest rate over the forecast period. This is due to increasing popularity of ambulatory surgical centres (ASCs). In the majority of healthcare facilities, corneal implant treatments are conducted as outpatient procedures. This market is expanding as a result of the decrease in in-patient surgeries and the rise in demand for minimally invasive procedures. The growth of this industry is also being supported by patient preferences for effective treatment and issues related to hospital-acquired infections.

Regional Markets

In 2022, North America region accounted for the highest revenue in the artificial corneal implants market and is expected to maintain its dominance during the forecast period. This is attributed to the prevalence of a sizable patient pool, the accessibility of technologically improved technologies that make the procedures easy, and favourable reimbursement framework. Additionally, the regional governments' rising emphasis on R&D activities is a major factor in this region's market growth. The market for artificial corneal implants in this region is also anticipated to be driven by the lack of human cornea despite the U.S. with the largest number of donors. The market is anticipated to grow at its highest CAGR in Asia Pacific over the forecast period. The market in this region is expanding as a result of existence of manufacturers, large patient pools in countries including China and India, and regional product launch. Additionally, the market is expanding significantly as a result of rising disposable income and high knowledge of ocular disorders.

Competitor Insights

Some of the key players operating in the artificial corneal implants market are SightLife, Advancing Sight Network, DIOPTEX Medizinprodukte Forschungs, KeraMed, Inc., CorneaGen, LinkoCare Life Sciences AB, San Diego Eye Bank, Mediphacos, Beijing Microkpro Medical Instrument Co. Ltd., AJL Ophthalmic, Florida Lions Eye Bank, Aurolab, Addition Technology, Massachusetts Eye and Ear, FCI Ophthalmics, Inc., Presbia plc, Cornea Biosciences, and EyeYon.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

For instance, in June 2021, EyeYon acquired the CE Mark for its EndoArt, the first synthetic implant in the world that substitutes the human endothelium, which cannot be regenerated by the human body, after clinical trials demonstrated the safety and efficacy for treating chronic corneal edoema.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including transplant type, indication, implant type, and end use from 2023 to 2033.

Segmentation: Artificial Corneal Implants Market Report 2022 - 2033

Transplant Type (Revenue, USD Million), 2022 - 2033

Soft Keratoprosthesis

Hard Keratoprosthesis

  • Osteo-Odonto-Keratoprosthesis
  • Boston Kpro

Indication (Revenue, USD Million), 2022 - 2033

  • Ocular Cicatricial Pemphigoid (OCP)
  • Stevens-Johnson syndrome (SJS)
  • Keratoconus
  • Ocular burns
  • Corneal stromal dystrophies
  • Others

Implant Type (Revenue, USD Million), 2022 - 2033

  • Biosynthetic
  • Synthetic

End Use (Revenue, USD Million), 2022 - 2033

  • Ambulatory Surgical Centers
  • Hospitals
  • Ophthalmic Centers

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Artificial Corneal Implants

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Artificial Corneal Implants Market

7. Market Analysis by Transplant Type
7.1. Soft Keratoprosthesis
7.1.1. Soft Keratoprosthesis Market Forecast, 2022-2033 (USD Million)
7.2. Hard Keratoprosthesis
7.2.1. Hard Keratoprosthesis Market Forecast, 2022-2033 (USD Million)
7.2.1.1. Osteo-Odonto-Keratoprosthesis
7.2.1.1.1. Osteo-Odonto-Keratoprosthesis Market Forecast, 2022-2033 (USD Million)
7.2.1.2. Boston Kpro
7.2.1.2.1. Boston Kpro Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Indication
8.1. Ocular Cicatricial Pemphigoid (OCP)
8.1.1. Ocular Cicatricial Pemphigoid (OCP) Market Forecast, 2022-2033 (USD Million)
8.2. Stevens-Johnson syndrome (SJS)
8.2.1. Stevens-Johnson syndrome (SJS) Market Forecast, 2022-2033 (USD Million)
8.3. Keratoconus
8.3.1. Keratoconus Market Forecast, 2022-2033 (USD Million)
8.4. Ocular burns
8.4.1. Ocular burns Market Forecast, 2022-2033 (USD Million)
8.5. Corneal stromal dystrophies
8.5.1. Corneal stromal dystrophies Market Forecast, 2022-2033 (USD Million)
8.6. Others
8.6.1. Others Market Forecast, 2022-2033 (USD Million)

9. Market Analysis by Implant Type
9.1. Biosynthetic
9.1.1. Biosynthetic Market Forecast, 2022-2033 (USD Million)
9.2. Synthetic
9.2.1. Synthetic Market Forecast, 2022-2033 (USD Million)

10. Market Analysis by End Use
10.1. Ambulatory Surgical Centers
10.1.1. Ambulatory Surgical Centers Market Forecast, 2022-2033 (USD Million)
10.2. Hospitals
10.2.1. Hospitals Market Forecast, 2022-2033 (USD Million)
10.3. Ophthalmic Centers
10.3.1. Ophthalmic Centers Market Forecast, 2022-2033 (USD Million)

10. Regional Market Analysis
10.2. Regional Market Trends

11. North America Artificial Corneal Implants Market
10.1. North America Artificial Corneal Implants Market
10.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
10.1.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
10.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
10.2. U.S. Artificial Corneal Implants Market
10.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
10.2.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
10.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
10.3. Canada Artificial Corneal Implants Market
10.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
10.3.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
10.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

11. Europe Artificial Corneal Implants Market
11.1. Europe Artificial Corneal Implants Market
11.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
11.1.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
11.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.2. Germany Artificial Corneal Implants Market
11.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
11.2.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
11.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.3. UK Artificial Corneal Implants Market
11.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
11.3.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
11.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.4. France Artificial Corneal Implants Market
11.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
11.4.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
11.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.5. Spain Artificial Corneal Implants Market
11.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
11.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.6. Italy Artificial Corneal Implants Market
11.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
11.6.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
11.6.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
11.7. Rest of EuropeArtificial Corneal Implants Market
11.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
11.7.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
11.7.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

12. Asia PacificArtificial Corneal Implants Market
12.1. Asia PacificArtificial Corneal Implants Market
12.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
12.1.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
12.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.2. Japan Artificial Corneal Implants Market
12.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
12.2.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
12.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.3. China Artificial Corneal Implants Market
12.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
12.3.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
12.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.4. India Artificial Corneal Implants Market
12.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
12.4.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
12.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.5. South Korea Artificial Corneal Implants Market
12.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
12.5.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
12.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.6. Australia Artificial Corneal Implants Market
12.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
12.6.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
12.6.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
12.6.1.3. Market Size and Forecast by Implant Type 2022-2033 (USD Million)
12.6.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
12.7. Rest of Asia Pacific Artificial Corneal Implants Market
12.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
12.7.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
12.7.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
12.7.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
12.7.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

13. Latin America Artificial Corneal Implants Market
13.1. Latin America Artificial Corneal Implants Market
13.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
13.1.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
13.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.2. BrazilArtificial Corneal Implants Market
13.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
13.2.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
13.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.3. MexicoArtificial Corneal Implants Market
13.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
13.3.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
13.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.4. Argentina Artificial Corneal Implants Market
13.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
13.4.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
13.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
13.5. Rest of Latin America Artificial Corneal Implants Market
13.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
13.5.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
13.5.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
13.5.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
13.5.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

14. MEAArtificial Corneal Implants Market
14.1. MEA Artificial Corneal Implants Market
14.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
14.1.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
14.1.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
14.1.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
14.1.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.2. GCC Artificial Corneal Implants Market
14.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
14.2.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
14.2.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
14.2.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
14.2.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.3. South Africa Artificial Corneal Implants Market
14.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
14.3.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
14.3.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
14.3.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
14.3.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)
14.4. Rest of MEA Artificial Corneal Implants Market
14.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
14.4.1.1. Market Size and Forecast by Transplant Type, 2022-2033 (USD Million)
14.4.1.2. Market Size and Forecast by Indication, 2022-2033 (USD Million)
14.4.1.3. Market Size and Forecast by Implant Type, 2022-2033 (USD Million)
14.4.1.4. Market Size and Forecast by End Use, 2022-2033 (USD Million)

15. Competitor Analysis
15.1. Market Share Analysis, 2022
15.2. Major Recent Developments, 2019-2022

16. Company Profiles
16.1. SightLife
16.1.1. Company Snapshot
16.1.2. Company Overview
16.1.3. Financial Analysis
16.1.4. Product Benchmarking
16.1.5. Recent Developments
16.2. Advancing Sight Network
16.2.1. Company Snapshot
16.2.2. Company Overview
16.2.3. Financial Analysis
16.2.4. Product Benchmarking
16.2.5. Recent Developments
16.3. DIOPTEX Medizinprodukte Forschungs
16.3.1. Company Snapshot
16.3.2. Company Overview
16.3.3. Financial Analysis
16.3.4. Product Benchmarking
16.3.5. Recent Developments
16.4. KeraMed, Inc.
16.4.1. Company Snapshot
16.4.2. Company Overview
16.4.3. Financial Analysis
16.4.4. Product Benchmarking
16.4.5. Recent Developments
16.5. CorneaGen
16.5.1. Company Snapshot
16.5.2. Company Overview
16.5.3. Financial Analysis
16.5.4. Product Benchmarking
16.5.5. Recent Developments
16.6. LinkoCare Life Sciences AB
16.6.1. Company Snapshot
16.6.2. Company Overview
16.6.3. Financial Analysis
16.6.4. Product Benchmarking
16.6.5. Recent Developments
16.7. San Diego Eye Bank
16.7.1. Company Snapshot
16.7.2. Company Overview
16.7.3. Financial Analysis
16.7.4. Product Benchmarking
16.7.5. Recent Developments
16.8. Mediphacos
16.8.1. Company Snapshot
16.8.2. Company Overview
16.8.3. Financial Analysis
16.8.4. Product Benchmarking
16.8.5. Recent Developments
16.9. Beijing Microkpro Medical Instrument Co. Ltd.
16.9.1. Company Snapshot
16.9.2. Company Overview
16.9.3. Financial Analysis
16.9.4. Product Benchmarking
16.9.5. Recent Developments
16.10. AJL Ophthalmic
16.10.1. Company Snapshot
16.10.2. Company Overview
16.10.3. Financial Analysis
16.10.4. Product Benchmarking
16.10.5. Recent Developments
16.11. Florida Lions Eye Bank
16.11.1. Company Snapshot
16.11.2. Company Overview
16.11.3. Financials
16.11.4. Indication Benchmarking
16.11.5. Recent Developments
16.12. Aurolab
16.12.1. Company Snapshot
16.12.2. Company Overview
16.12.3. Financials
16.12.4. Indication Benchmarking
16.12.5. Recent Developments
16.13. Addition Technology
16.13.1. Company Snapshot
16.13.2. Company Overview
16.13.3. Financials
16.13.4. Indication Benchmarking
16.13.5. Recent Developments
16.14. Massachusetts Eye and Ear
16.14.1. Company Snapshot
16.14.2. Company Overview
16.14.3. Financials
16.14.4. Indication Benchmarking
16.14.5. Recent Developments
16.15. FCI Ophthalmics, Inc.
16.15.1. Company Snapshot
16.15.2. Company Overview
16.15.3. Financials
16.15.4. Indication Benchmarking
16.15.5. Recent Developments
16.16. Others Prominent Players

17. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • SightLife
  • Advancing Sight Network
  • DIOPTEX Medizinprodukte Forschungs
  • KeraMed Inc.
  • CorneaGen
  • LinkoCare Life Sciences AB
  • San Diego Eye Bank
  • Mediphacos
  • Beijing Microkpro Medical Instrument Co. Ltd.
  • AJL Ophthalmic
  • Florida Lions Eye Bank
  • Aurolab
  • Addition Technology
  • Massachusetts Eye and Ear
  • FCI Ophthalmics Inc.
  • Presbia plc
  • Cornea Biosciences
  • EyeYon.